. But producing and supplying billions of doses remain major concerns as the fast-spreading respiratory illness overwhelms health care systems around the world.“We will continue to collaborate globally to ensure sufficient worldwide supply,” Gilead chief executive officer Daniel O’Day said in aTwo major Indian drugmakers – Hetero Labs and Cipla Ltd – on Sunday gained approval to begin selling their generic versions of remdesivir in the country.
Gilead said an inhaled formulation of the drug would be given through a nebulizer, which could potentially allow for easier use outside hospitals.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Flunked its ebola vaccine trials, teetering with investors, till raised from the dead...drug touted by Trump.